Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. HUM
8. CSCO
9. KTOS
10. NVDA

Go back to Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results

Sangamo Therapeutics (SGMO) Misses Q1 EPS by 2c, Revenues Beat

May 4, 2021 5:24 PM EDT

Sangamo Therapeutics (NASDAQ: SGMO) reported Q1 EPS of ($0.32), $0.02 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $26.28 million versus the consensus estimate of $23.98 million.

This quarter, we have continued our focus on advancing our lead programs through clinical execution, regulatory... More